Jill Jussli-Melchers, Christine Friedrich, Kira Mandler, Mohamad Hosam Alosh, Mohamed Ahmed Salem, Jan Schoettler, Jochen Cremer, Assad Haneya
{"title":"感染性心内膜炎术后 30 天死亡率的风险因素分析。","authors":"Jill Jussli-Melchers, Christine Friedrich, Kira Mandler, Mohamad Hosam Alosh, Mohamed Ahmed Salem, Jan Schoettler, Jochen Cremer, Assad Haneya","doi":"10.1055/s-0044-1779709","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong> Infective endocarditis (IE) remains a challenging disease associated with high mortality. Several scores have been suggested to assess surgical risk. None was sufficiently adequate. We therefore analyzed risk factors for 30-day mortality.</p><p><strong>Methods: </strong> A total of 438 consecutive patients had surgery for IE in our department between 2002 and 2020. Patients were divided into two groups, one consisting of 30-day survivors (362 patients; 82.6%) and one of nonsurvivors (76 patients; 17.4%). Logistic regression analysis on pre- and intraoperative risk factors was performed and the groups were compared by univariable analyses.</p><p><strong>Results: </strong> Patients in mortality group were older (69 [58, 77] vs. 63 [50, 72] years; <i>p</i> < 0.001), EuroSCORE II was higher (24.5 [12.1, 49.0] vs. 8.95 [3.7, 21.2]; <i>p</i> < 0.001) and there were more females. More frequently left ventricular function (below 30%), preoperative acute renal insufficiency, chronic dialysis, insulin-dependent diabetes mellitus, NYHA-class IV (New York Heart Association heart failure class IV), and cardiogenic shock occurred. Patients in the mortality group were often intensive care unit patients (40.8 vs. 22.4%; <i>p</i> < 0.001) or had a preoperative stroke (26.3 vs. 16.0%; <i>p</i> = 0.033). In the nonsurvivor group <i>Staphylococcus aureus</i> was prevalent. <i>Streptococcus viridans</i> was common in the survivor group as was isolated aortic valve endocarditis (32.9 vs. 17.1%; <i>p</i> = 0.006). Prosthetic valve endocarditis (PVE) and abscesses occurred more often in nonsurvivors. In the logistic regression analysis, female gender, chronic dialysis, cardiogenic shock, and NYHA IV and from intraoperative variables PVE, cardiopulmonary bypass time, and mitral valve surgery were the strongest predictors for 30-day mortality.</p><p><strong>Conclusion: </strong> This study indeed clearly indicates that significant risk factors for 30-day mortality cannot be changed. Nevertheless, they should be taken into account for preoperative counselling, and they will alert the surgical team for an even more careful management.</p>","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":" ","pages":"595-606"},"PeriodicalIF":1.3000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597187/pdf/","citationCount":"0","resultStr":"{\"title\":\"Risk Factor Analysis for 30-day Mortality After Surgery for Infective Endocarditis.\",\"authors\":\"Jill Jussli-Melchers, Christine Friedrich, Kira Mandler, Mohamad Hosam Alosh, Mohamed Ahmed Salem, Jan Schoettler, Jochen Cremer, Assad Haneya\",\"doi\":\"10.1055/s-0044-1779709\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong> Infective endocarditis (IE) remains a challenging disease associated with high mortality. Several scores have been suggested to assess surgical risk. None was sufficiently adequate. We therefore analyzed risk factors for 30-day mortality.</p><p><strong>Methods: </strong> A total of 438 consecutive patients had surgery for IE in our department between 2002 and 2020. Patients were divided into two groups, one consisting of 30-day survivors (362 patients; 82.6%) and one of nonsurvivors (76 patients; 17.4%). Logistic regression analysis on pre- and intraoperative risk factors was performed and the groups were compared by univariable analyses.</p><p><strong>Results: </strong> Patients in mortality group were older (69 [58, 77] vs. 63 [50, 72] years; <i>p</i> < 0.001), EuroSCORE II was higher (24.5 [12.1, 49.0] vs. 8.95 [3.7, 21.2]; <i>p</i> < 0.001) and there were more females. More frequently left ventricular function (below 30%), preoperative acute renal insufficiency, chronic dialysis, insulin-dependent diabetes mellitus, NYHA-class IV (New York Heart Association heart failure class IV), and cardiogenic shock occurred. Patients in the mortality group were often intensive care unit patients (40.8 vs. 22.4%; <i>p</i> < 0.001) or had a preoperative stroke (26.3 vs. 16.0%; <i>p</i> = 0.033). In the nonsurvivor group <i>Staphylococcus aureus</i> was prevalent. <i>Streptococcus viridans</i> was common in the survivor group as was isolated aortic valve endocarditis (32.9 vs. 17.1%; <i>p</i> = 0.006). Prosthetic valve endocarditis (PVE) and abscesses occurred more often in nonsurvivors. In the logistic regression analysis, female gender, chronic dialysis, cardiogenic shock, and NYHA IV and from intraoperative variables PVE, cardiopulmonary bypass time, and mitral valve surgery were the strongest predictors for 30-day mortality.</p><p><strong>Conclusion: </strong> This study indeed clearly indicates that significant risk factors for 30-day mortality cannot be changed. Nevertheless, they should be taken into account for preoperative counselling, and they will alert the surgical team for an even more careful management.</p>\",\"PeriodicalId\":23057,\"journal\":{\"name\":\"Thoracic and Cardiovascular Surgeon\",\"volume\":\" \",\"pages\":\"595-606\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597187/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thoracic and Cardiovascular Surgeon\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0044-1779709\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thoracic and Cardiovascular Surgeon","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/s-0044-1779709","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景:感染性心内膜炎(IE)仍然是一种具有挑战性的疾病,死亡率很高。已经提出了几种评估手术风险的评分方法。但没有一项足够充分。因此,我们分析了30天死亡率的风险因素:方法:2002 年至 2020 年间,共有 438 名连续患者在我科接受了 IE 手术。患者分为两组,一组为 30 天存活患者(362 例;82.6%),另一组为非存活患者(76 例;17.4%)。对术前和术后风险因素进行了逻辑回归分析,并通过单变量分析对两组进行了比较:结果:死亡组患者年龄较大(69 [58, 77] 岁 vs. 63 [50, 72] 岁;p p p = 0.033)。在非死亡组中,金黄色葡萄球菌最常见。病毒性链球菌和孤立性主动脉瓣心内膜炎(32.9% 对 17.1%;P = 0.006)在幸存者组很常见。人工瓣膜心内膜炎(PVE)和脓肿在非幸存者中发生率更高。在逻辑回归分析中,女性性别、慢性透析、心源性休克和 NYHA IV 以及术中变量 PVE、心肺旁路时间和二尖瓣手术是 30 天死亡率的最强预测因素:这项研究确实清楚地表明,30 天死亡率的重要风险因素是无法改变的。尽管如此,在术前咨询时应考虑到这些因素,并提醒手术团队采取更谨慎的管理措施。
Risk Factor Analysis for 30-day Mortality After Surgery for Infective Endocarditis.
Background: Infective endocarditis (IE) remains a challenging disease associated with high mortality. Several scores have been suggested to assess surgical risk. None was sufficiently adequate. We therefore analyzed risk factors for 30-day mortality.
Methods: A total of 438 consecutive patients had surgery for IE in our department between 2002 and 2020. Patients were divided into two groups, one consisting of 30-day survivors (362 patients; 82.6%) and one of nonsurvivors (76 patients; 17.4%). Logistic regression analysis on pre- and intraoperative risk factors was performed and the groups were compared by univariable analyses.
Results: Patients in mortality group were older (69 [58, 77] vs. 63 [50, 72] years; p < 0.001), EuroSCORE II was higher (24.5 [12.1, 49.0] vs. 8.95 [3.7, 21.2]; p < 0.001) and there were more females. More frequently left ventricular function (below 30%), preoperative acute renal insufficiency, chronic dialysis, insulin-dependent diabetes mellitus, NYHA-class IV (New York Heart Association heart failure class IV), and cardiogenic shock occurred. Patients in the mortality group were often intensive care unit patients (40.8 vs. 22.4%; p < 0.001) or had a preoperative stroke (26.3 vs. 16.0%; p = 0.033). In the nonsurvivor group Staphylococcus aureus was prevalent. Streptococcus viridans was common in the survivor group as was isolated aortic valve endocarditis (32.9 vs. 17.1%; p = 0.006). Prosthetic valve endocarditis (PVE) and abscesses occurred more often in nonsurvivors. In the logistic regression analysis, female gender, chronic dialysis, cardiogenic shock, and NYHA IV and from intraoperative variables PVE, cardiopulmonary bypass time, and mitral valve surgery were the strongest predictors for 30-day mortality.
Conclusion: This study indeed clearly indicates that significant risk factors for 30-day mortality cannot be changed. Nevertheless, they should be taken into account for preoperative counselling, and they will alert the surgical team for an even more careful management.
期刊介绍:
The Thoracic and Cardiovascular Surgeon publishes articles of the highest standard from internationally recognized thoracic and cardiovascular surgeons, cardiologists, anesthesiologists, physiologists, and pathologists. This journal is an essential resource for anyone working in this field.
Original articles, short communications, reviews and important meeting announcements keep you abreast of key clinical advances, as well as providing the theoretical background of cardiovascular and thoracic surgery. Case reports are published in our Open Access companion journal The Thoracic and Cardiovascular Surgeon Reports.